Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Thermo Fisher Scientific Inc. is proposing to build a new “corporate hangar and office facility” at the Portsmouth ...

Thermo Fisher Scientific Inc. (TMO) announced Friday that its Board of Directors has authorized the repurchase of $4 billion of ...

Mainz Biomed (MYNZ) announced a collaborative agreement with Thermo Fisher Scientific (TMO), through its subsidiary Life Technologies. The ...

Thermo Fisher Scientific's board has approved a new $4 billion stock buyback program. The Waltham, Mass., Life-sciences giant on Friday said the new program has no expiration date and replaces its ...

Seer also announced a co-marketing and sales agreement with Thermo Fisher Scientific to jointly promote Proteograph alongside ...

The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.

I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact ...

Thermo Fisher Scientific's Q3 revenue of $10.59 billion missed expectations. Adjusted EPS beat estimates but dropped ...

On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted third-quarter revenue of $10.59 billion, almost flat year over year, marginally missing the consensus of $10.64 billion. Revenue ...